Efficacy and Safety of Intravaginal Estrogen in the Treatment of Atrophic Vaginitis: A Systematic Review and Meta-Analysis

키워드

참고문헌 (36)

1. Kim HK, "The recent review of the genitourinary syndrome of menopause", J Menopausal Med, 21, pp.65~71 (2015)
2. Campbell S, "Oestrogen therapy and the menopausal syndrome", Clin Obstet Gynaecol, 4, pp.31~47 (1977)
3. Suckling J, "Local oestrogen for vaginal atrophy in postmenopausal women", Cochrane Database Syst Rev, 4, pp.CD001500~ (2006)
4. Heimer G, "Estriol : absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal", Acta Obstet Gynecol Scand, 63, pp.563~567 (1984)
5. Smith RN, "Recent advances in hormone replacement therapy", Br J Hosp Med, 49, pp.799~808 (1993)
6. Bachmann GA, "Long term nonhormonal treatment of vaginal dryness", Clin Pract Sex, 8, pp.3~8 (1992)
7. Cardozo L, "Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women : second report of the Hormones and Urogenital Therapy Committee", Obstet Gynecol, 92, pp.722~727 (1998)
8. Dessole S, "Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women", Menopause, 11, pp.49~56 (2004)
9. Simon J, "Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet", Obstet Gynecol, 112, pp.1053~1060 (2008)
10. Derzko CM, "Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets", Menopause, 28, pp.113~118 (2020)
11. AWHONN Lifelines, "ACOG issues hormone therapy guidelines. Experts expand estrogen advice; renounce herbs for hot flashes", AWHONN Lifelines, 9, pp.39~42 (2005)
12. Baber RJ, "2016 IMS recommendations on women’s midlife health and menopause hormone therapy", Climacteric, 19, pp.109~150 (2016)
13. Lethaby A, "Local oestrogen for vaginal atrophy in postmenopausal women", Cochrane Database Syst Rev, 2016, pp.CD001500~ (2016)
14. Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", PLoS Med, 6, pp.e1000097~ (2009)
15. Cumpston M, "Updated guidance for trusted systematic reviews : a new edition of the Cochrane handbook for systematic reviews of interventions", Cochrane Database Syst Rev, 10, pp.ED000142~ (2019)
16. Archer DF, "A randomized, multicenter, double-blind, study to evaluate the safety and efficacy of estradiol vaginal cream 0. 003% in postmenopausal women with vaginal dryness as the most bothersome symptom", J Womens Health (Larchmt), 27, pp.231~237 (2018)
17. Cano A, "The therapeutic effect of a new ultra low concentration estriol gel formulation(0. 005% estriol vaginal gel)on symptoms and signs of postmenopausal vaginal atrophy : results from a pivotal phase III study", Menopause, 19, pp.1130~1139 (2012)
18. Casper F, "Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring : a comparative and a placebocontrolled multicenter study. Vaginal Ring Study Group", Int Urogynecol J Pelvic Floor Dysfunct, 10, pp.171~176 (1999)
19. Constantine GD, "The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy", Menopause, 24, pp.409~416 (2017)
20. Delgado JL, "Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women", Climacteric, 19, pp.172~180 (2016)
21. Fernandes T, "Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy : a randomized controlled trial", Menopause, 23, pp.792~798 (2016)
22. Gaspard U, "A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants(E4Relief) : part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life", Menopause, 30, pp.480~489 (2023)
23. Bachmann G, "Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis : a randomized controlled trial", Obstet Gynecol, 111, pp.67~76 (2008)
24. Bachmann G, "Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally", Menopause, 16, pp.719~727 (2009)
25. Griesser H, "Low dose estriol pessaries for the treatment of vaginal atrophy : a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0. 2mg and 0. 03mg estriol", Maturitas, 71, pp.360~368 (2012)
26. Hirschberg AL, "Efficacy and safety of ultra-low dose 0. 005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors : a phase II, randomized, double-blind, placebo-controlled trial", Menopause, 27, pp.526~534 (2020)
27. Kroll R, "A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0. 003% in postmenopausal women with dyspareunia as the most bothersome symptom", Menopause, 25, pp.133~138 (2018)
28. Lima SM, "Effective treatment of vaginal atrophy with isoflavone vaginal gel", Maturitas, 74, pp.252~258 (2013)
29. Mitchell CM, "Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms : a randomized clinical trial", JAMA Intern Med, 178, pp.681~690 (2018)
30. Pickar JH, "A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol", Menopause, 23, pp.506~510 (2016)
31. Raghunandan C, "A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women", J Sex Med, 7, pp.1284~1290 (2010)
32. Bleibel B, "Vaginal atrophy" (2024), StatPearls Publishing
33. Xu XL, "Estrogen biosynthesis and signal transduction in ovarian disease", Front Endocrinol, 13, pp.827032~ (2022)
34. Kingsberg S, "Treating dyspareunia caused by vaginal atrophy : a review of treatment options using vaginal estrogen therapy", Int J Womens Health, 1, pp.105~111 (2010)
35. North American Menopause Society, "The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women : 2007 position statement of The North American Menopause Society", Menopause, 14, pp.355~369 (2007)
36. Simon JA, "Clarifying vaginal atrophy, s impact on sex and relationships(CLOSER)survey : emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners", Menopause, 21, pp.137~142 (2014)

관련 논문AI추천